
Quality over quantity: The case for total shareholder yield
With so many potential pitfalls, the Bloomberg Shareholder Yield Index (BSHARP) takes a more refined approach to identifying companies with high shareholder yield. The index examines the total return of capital, which includes dividends paid, net buybacks, as well as debt repayment.
Within this framework, shareholder yield is total returned capital as a percentage of the company's market capitalization. Examining debt levels achieves two objectives. While debt is an important metric in measuring quality, it also may identify companies whose interest expense may decrease, which could benefit equity investors moving forward. The index also analyzes a company's total return of capital in comparison with its free cash flow. This helps to ensure that the value a company returns to its shareholders in the form of dividends, buybacks, and debt repayment is within its capacity.
To be eligible for inclusion in the index, a company must be part of the Bloomberg US large & mid cap universe excluding real estate investment trusts and pass certain tradability thresholds. More importantly, a company must have positive total returned capital, positive free cash flow, and capacity (total returned capital as a portion of free cash flow) below 150% for the trailing five years. Of the companies that remain, the largest 50 companies by total returned capital are selected for inclusion. The index is weighted according to each company's shareholder yield, with companies that have high shareholder yield having a higher allocation in the index.
A current index constituent that demonstrates the Bloomberg Index approach to total shareholder yield is Altria (NYSE: MO). The company pays a dividend above the broad market, with a trailing yield of over 6% (vs 1.3% for the Bloomberg 1000). At the same time, the company bought back over $3 billion in shares last year. Altria was able to do so without taking on more debt. In fact, the amount of long-term debt the company has outstanding has dropped by over 6% year-over-year. The combination of dividends, share repurchases, and debt repayment results in a total shareholder yield of 11%. There is even room for this to continue and grow, as Altria has been able to return cash to shareholders through robust free-cash-flow, which has remained north of $8 billion for the past 5 calendar years.
Identifying under-the-radar companies
Using this multipronged approach to shareholder yield helps to identify companies that might otherwise fly under the radar. Paying an above-average dividend, for example, is not a requirement for the Bloomberg Shareholder Yield Index. KLA Corp (NASDAQ: KLAC) may seem like an outlier as the company pays only a small dividend, but it has provided attractive total shareholder yield due to a robust share repurchase program.
In fact, the company recently announced an expansion of that program, authorizing an additional $5 billion in stock buybacks. The company has been able to achieve this while also reducing debt outstanding, with the resulting shareholder yield totaling nearly 4%. Despite low and non-dividend paying stocks being eligible for the index, the overall yield of the constituents in aggregate is still noticeably higher than that of the broad market. In fact, that gap has recently widened, as 95% of the dividend paying stocks within the index have grown their dividend amount over the past year.
Taking a closer look at the balance sheet
This methodology helps avoid names that a simplistic approach may otherwise include. Take Ford (NYSE: F) for example. With an attractive yield of roughly 6%, the company is a constituent of many dividend indices. But Ford has also been a net issuer of both stock and debt. Another is Diamondback Energy (NASDAQ: FANG), which at first glance seems like a stock with strong shareholder yield. The company has an above-average dividend yield and a stock buyback program. But examining the balance sheet reveals a meaningful increase in debt, which more than offsets the dividends and share repurchase. In both instances, the shareholder yield is negative, something dividend yield would never be.
From a factor perspective, the Bloomberg Shareholder Yield Index goes beyond delivering exposure to value and dividend yield factors when compared to the broad market. Using the TLTS function on the Terminal highlights exposure to quality and lower volatility companies relative to the market cap weighted Bloomberg 1000 Index. Looking further, when we compare BSHARP to a value benchmark, the index delivers the same expected tilts, but without sacrificing quality.
Dividend and shareholder yield strategies are often associated with value investing, yet the BSHARP Index outperformed the broad market over the 10-year period, one defined by the significant contribution of growth names to broad market returns. Even still, the primary contributor to returns was earnings expansion rather than multiple expansion, as the trailing P/E of the index has remained relatively constant over that same period.
Conclusion
Equity markets have been volatile this year. Investors are adjusting their allocations accordingly, with income, quality, and low-volatility strategies of particular interest. The Bloomberg Shareholder Yield Index employs a multi-faceted approach to identify companies returning capital to shareholders in a responsible and repeatable way.
The methodology seeks to avoid missteps that overly simplistic approaches may fall into by going beyond superficial data points to take a more holistic approach to shareholder yield. The result is an index consisting of 'shareholder-friendly' companies that have a track record of consistency and quality, traits that may help investors navigate the current environment. Investors can gain exposure to the companies in the BSHARP Index through an ETF offered by First Trust, ticker SHRY.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
UnitedHealth Group (UNH) Responds to the Department of Justice
UnitedHealth Group Incorporated (NYSE:UNH) is one of the top low volatility healthcare stocks to buy now. On July 24, UnitedHealth Group Incorporated (NYSE:UNH) released a statement responding to the Department of Justice after a review of the media reports about investigations into specific aspects of its involvement in the Medicare program. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH) stated that it has now begun complying with the formal criminal and civil requests from the Department, and has 'full confidence in its practices and is committed to working cooperatively with the Department throughout this process'. It added that UnitedHealth Group Incorporated (NYSE:UNH) has a historical record of 'responsible conduct and effective compliance,' with independent CMS audits showing that its practices are ranked 'among the most accurate in the industry.' Management stated that after a decade-long civil challenge by the Department to aspects of the company's Medicare Advantage business, 'a court-appointed Special Master concluded there was no evidence to support claims of wrongdoing'. UnitedHealth Group Incorporated (NYSE:UNH) has launched its own initiative to provide confidence and transparency to stakeholders, focusing on conducting 'third-party reviews of policies, practices, and associated processes and performance metrics for risk assessment coding, managed care practices, and pharmacy services.' UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments, which have solid operations. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.


Entrepreneur
7 minutes ago
- Entrepreneur
Meta Appoints Ex-OpenAI Scientist Shengjia Zhao to Lead New Superintelligence Lab
Zhao, previously a research scientist at OpenAI, played a pivotal role in creating GPT-4 and various lighter models such as version 4.1 and o3. He is among at least eight researchers who have recently transitioned from OpenAI to Meta. You're reading Entrepreneur India, an international franchise of Entrepreneur Media. Meta Platforms has appointed Shengjia Zhao, a leading figure in the development of OpenAI's ChatGPT, as chief scientist of its newly launched Superintelligence Lab. This high-profile move marks a significant step in Meta's accelerating drive to position itself at the forefront of advanced artificial intelligence. CEO Mark Zuckerberg shared the announcement on Friday through Threads. He said Zhao will guide the lab's scientific direction and collaborate closely with both Zuckerberg and Meta's Chief AI Officer Alexandr Wang. Wang joined the company earlier this year after Meta took a substantial stake in his former company, Scale AI. Zhao, previously a research scientist at OpenAI, played a pivotal role in creating GPT-4 and various lighter models such as version 4.1 and o3. He is among at least eight researchers who have recently transitioned from OpenAI to Meta. The influx of talent signals Meta's intent to rapidly close the distance with competitors in the race toward building artificial general intelligence. The creation of the Superintelligence Lab is part of Meta's broader efforts to establish a premier AI research division. The lab is distinct from FAIR, Meta's long-standing AI unit led by deep learning pioneer Yann LeCun. While FAIR has focused on foundational research, the new lab aims to develop what Zuckerberg has described as full general intelligence. Zuckerberg also confirmed that Meta plans to open-source the work produced by the Superintelligence Lab. This strategy has drawn mixed reactions within the AI community, with some praising the transparency and others warning of risks linked to such openness. Meanwhile, Meta's recruitment campaign has unsettled OpenAI. Internal messages leaked this month revealed OpenAI Chief Research Officer Mark Chen comparing Meta's tactics to "someone breaking into our home and stealing something." In response, OpenAI is reportedly reassessing its compensation practices and offering staff additional time off to curb further departures. OpenAI CEO Sam Altman has publicly criticised what he views as profit-driven hiring practices. He alleged that Meta has lured researchers with offers reaching USD 100 million in signing bonuses, a claim dismissed as exaggerated by Meta's Chief Technology Officer Andrew Bosworth. However, reports of even higher offers, including an unverified USD 1.25 billion compensation package over four years, illustrate the escalating competition for elite AI talent. While Altman argues that OpenAI's mission-focused approach offers a stronger long-term foundation, others in the industry see Meta's strategy as justified. Google DeepMind's CEO Demis Hassabis called the hiring surge a rational response given Meta's desire to catch up. With over USD 14 billion invested in AI infrastructure and partnerships, Meta is making its intentions clear. The addition of Zhao and other key hires underscores the company's determination to lead—not just follow—the next wave of AI development.


Forbes
8 minutes ago
- Forbes
Musk Announces Deal With Samsung For Tesla AI Chips Made In Texas
Tesla CEO Elon Musk announced late on Sunday that Samsung will manufacture the car maker's next-generation AI chip at its upcoming Texas semiconductor plant as part of a deal worth $16.5 billion, in a significant boost for Samsung's struggling chipmaking arm. Tesla CEO Elon Musk announced that Samsung will manufacture Tesla's next-generation AI chips. Getty Images In a post on X, Musk announced that 'Samsung's giant new Texas fab will be dedicated to making Tesla's next-generation AI6 chip,' adding: 'The strategic importance of this is hard to overstate.' In a regulatory filing made in South Korea shortly before Musk's announcement, the electronics giant announced it had secured a $16.5 billion contract with a 'large global company.' The multi-year deal will run through till the end of 2033, and Samsung's semiconductor fabrication plant in Taylor, Texas, is scheduled to begin operations in 2026. In a follow-up post, Musk said Samsung has agreed to 'allow Tesla to assist in maximizing manufacturing efficiency,' but he didn't specify whether this meant Tesla would assist in bringing the plant into operation. Musk pointed out the Samsung fab 'is conveniently located not far from my house' and claimed he would walk the production line 'personally to accelerate the pace of progress.' Musk pointed out that Samsung currently manufactures Tesla's AI4 chip. The billionaire said his company has completed the design for the AI5 chip, which will be manufactured by TSMC, Samsung's primary chipmaking rival. According to Musk, the AI5 chips will be first manufactured in Taiwan and then later at TSMC's Arizona plant. How Have The Markets Reacted? Shortly after the announcement, Samsung Electronics' Seoul-traded shares surged 6.22% to $50.6 (KRW 70,000).